THR-18 is an 18-mer peptide derived from the sequence of human plasminogen activator inhibitor 1 (PAI-1), having the ability to bind to a site of tissue plasminogen activator (tPA) distal to its catalytic site and uncouple the beneficial clot-dissolving properties of tPA from its deleterious non-fibrinolytic effects.
Molecular Weight:
2390.7742
CAS Number:
[1383452-03-6]
Formula:
C105H167F3N28O28S2
Target:
Others
T70810
* VAT and and shipping costs not included. Errors and price changes excepted